The vasculitis landscape is rapidly evolving with continuous advances in understanding mechanisms of disease, refinement of diagnostic tools and assessment methods, and improving and increasing treatment options.

Important therapeutic advances have been achieved over the past years widening the therapeutic horizon for patients who previously had limited opportunities mostly relying on treatments with marked toxicity. Emerging new concepts and approaches arise from collaboration and joint efforts among basic, clinical, and translational investigators working in academic or industry settings, as well as patient associations and advocacies.